Radiotherapy Dose Decision Support via Radiomic Feature Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radiotherapy treatments for cancer, such as non-small cell lung cancer, face challenges in predicting individual patient responses due to limitations in molecular characterization and reliance on invasive biopsies, with standard approaches failing to optimize outcomes for all patients, leading to treatment resistance and recurrence.
Innovation Solution
A machine-learned multi-task generator is employed to predict therapy outcomes using deep learning, integrating image features and non-image data, allowing for personalized dose determination and improved decision support by calibrating treatment strategies based on regression analysis and cumulative incidence functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standard radiotherapy approaches are used for population efficacy, then treatment effectiveness for average patients is improved, but individual patient outcomes deteriorate due to lack of personalization
Solution Approach 1:
The system performs preliminary extraction and analysis of radiomic features from medical images before treatment delivery, creating predictive models in advance that guide individualized dose determination. This preliminary characterization of tumor properties enables personalized treatment planning that adapts standard approaches to individual patient needs.
Solution Approach 2:
The system changes treatment parameters (radiation dose, fractionation) based on extracted radiomic features and predictive models. By adjusting dosimetric parameters according to individual tumor characteristics derived from imaging data, the system optimizes treatment for each patient while maintaining population-level efficacy standards.
2Adaptability or versatility
If molecular characterization using genomic and proteomic technologies is used, then treatment personalization is improved, but measurement capability deteriorates due to spatial and temporal heterogeneity requiring invasive biopsies
Solution Approach 1:
The system creates a non-invasive copy of tumor information through medical imaging (CT, MRI, PET) that captures spatial and temporal heterogeneity without requiring physical biopsy samples. Radiomic features extracted from these image copies provide comprehensive tumor characterization equivalent to molecular analysis but without invasive procedures.
Solution Approach 2:
Medical images serve as an intermediary between the tumor and the analysis system, enabling non-invasive extraction of radiomic features that reflect tumor biology. This intermediary approach avoids the limitations of direct biopsy while still providing actionable information for treatment personalization.
3Ease of operation
If tumor size is measured using one- or two-dimensional descriptors (RECIST, WHO), then monitoring simplicity is improved, but predictive information deteriorates due to insufficient outcome prediction capability
Solution Approach 1:
The system transitions from one- or two-dimensional tumor size measurements to high-dimensional radiomic feature extraction from three-dimensional medical images. This dimensional expansion captures additional tumor characteristics (texture, shape, intensity distribution) that provide predictive information about treatment response while maintaining clinical workflow simplicity.
4Ease of manufacture
If handcrafted radiomic features are extracted using pre-defined groups, then feature extraction systematicity is improved, but information capture deteriorates due to redundancy and irrelevance of pre-defined features
Solution Approach 1:
The system employs dynamic feature selection and extraction processes that adapt to the specific characteristics of each tumor and treatment scenario. Rather than applying fixed pre-defined feature groups, the system dynamically identifies and extracts relevant radiomic features based on the imaging data and clinical context, maximizing predictive information while minimizing redundancy.
Data Source
AI summary
For decision support in a medical therapy, machine learning provides a machine-learned generator for generating a prediction of outcome for therapy personalized to a patient. The outcome prediction may be used to determine dose. To assist in decision support, a regression analysis of the cohort used for machine training relates the outcome from the machine-learned generator to the dose and an actual control time (e.g., time-to-event). The dose that minimizes side effects while minimizing risk of failure to a time for any given patient is determined from the outcome for that patient and a calibration from the regression analysis.